
Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
Siddhartha Mukherjee, M.D., Ph.D, an oncologist, researcher and Pulitzer Prize-winning science writer, discusses the increasing awareness about myeloproliferative neoplasms (MPNs).
Siddhartha Mukherjee, M.D., Ph.D, an oncologist, researcher and Pulitzer Prize-winning science writer, discusses the increasing awareness about myeloproliferative neoplasms (MPNs).
For a long time, MPNs were quite "mysterious," Mukherjee said, noting that physicians had a difficult time diagnosing and characterizing them. But thanks to increasing awareness about MPN genetics, as well as the condition itself, physicians and patients have a better understanding on how to handle MPNs.





